市場調査レポート

商品コード

1293826

輸血診断市場 - 成長、将来展望、競合分析、2023年～2031年

Blood Transfusion Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日: 2023年06月05日 | 発行: Acute Market Reports

| ページ情報: 英文 112 Pages | 納期: 即日から翌営業日

価格

PDF (Single User License)

USD 4,500 705,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 6,500 1,018,940円

レポートPDFを10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,000 1,410,840円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

輸血診断市場は、安全で効率的な輸血の実践を確保するために重要な役割を果たす医療産業の重要なセグメントです。同市場は、2023年から2031年の予測期間中にCAGR7%で成長すると予測されています。この市場は、血液・血液製剤の需要の増加、輸血感染症に対する意識の高まり、正確で効率的な診断方法の必要性などが要因となっています。市場の収益は着実に伸びており、今後も上昇基調が続くと予想されます。市場の収益は、外科手術、外傷例、慢性疾患による輸血数の増加などの要因によって影響を受けます。さらに、血液関連疾患の有病率の上昇や老人人口の増加が、輸血診断の需要に寄与しています。技術の進歩により、正確で迅速な結果をもたらす革新的な診断方法が開発され、市場の成長をさらに後押ししています。近年、輸血感染症の予防と対策が重視されるようになっています。このため、厳しい規制ガイドラインや品質保証プログラムの導入が進み、先進的な輸血診断の採用が推進されています。市場は、従来の血清学的手法から、感度と特異性の向上を目的とした核酸検査（NAT）やその他の分子技術への移行を目の当たりにしています。

血液・血液製剤の需要拡大

血液・血液製剤の需要増は、輸血診断市場の主要な促進要因です。この需要は、外科手術や外傷、慢性疾患の治療など、さまざまな要因に起因しています。世界保健機関（WHO）によると、世界では毎年推定1億1,250万単位の献血が集められています。がんや心血管疾患など、治療中に輸血を必要とすることが多い疾患の有病率が高まっているため、輸血の需要はさらに高まると予想されます。

輸血感染症に対する意識の高まり

輸血感染症（TTI）に対する認識と懸念は高まっており、効果的な輸血診断の必要性を後押ししています。TTIとは、汚染された血液や血液製剤を輸血することで感染する可能性がある感染症のことです。医療当局や血液銀行による厳しい規制ガイドラインや品質保証プログラムの実施により、正確で信頼性の高い診断の重要性がさらに高まっています。例えば、米国の疾病管理予防センター（CDC）は、TTIのリスクを最小限に抑えるために、献血者のスクリーニングと検査に関するガイドラインを制定しています。このような意識の高まりから、核酸検査（NAT）をはじめとする、より高い感度と特異性で感染因子を検出する高度な診断方法が採用されるようになりました。

診断技術の進歩

診断技術の進歩は、輸血診断市場の成長に大きく寄与しています。精度の向上、迅速な結果、自動化の強化を実現する革新的な検査やシステムの開発は、輸血診断の分野に変革をもたらしました。例えば、ポリメラーゼ連鎖反応（PCR）やリアルタイムPCRなどのNAT技術の導入は、献血血液中の感染性物質の検出に革命をもたらしました。これらの分子ベースの方法は、高い感度と特異性を持ち、病原体の早期検出を可能にし、輸血による感染症のリスクを低減します。さらに、自動化やロボットの進歩により、検査室のプロセスが合理化され、輸血診断におけるスループットや効率性の向上が可能になりました。これらの技術的進歩は、安全な輸血を確実に行うための信頼性の高い効率的なツールを医療専門家に提供することで、市場を前進させ続けています。

規制上の課題と厳格なコンプライアンス要件

輸血診断市場における主要な抑制要因の1つは、規制上の課題と厳格なコンプライアンス要件の存在です。輸血プロセスには、血液製剤の安全性と品質を確保することを目的としたいくつかの規制基準やガイドラインがあります。これらの規制は、輸血による感染症やその他の有害事象のリスクを最小化するために実施されています。しかし、これらの規制を遵守することは、医療施設や血液銀行にとって複雑で資源を必要とする場合があります。規制当局の承認取得、検証試験の実施、品質管理措置の遵守などのプロセスには、時間とコストがかかることがあります。さらに、規制基準の絶え間ない更新と改訂は、業界関係者が直面する課題をさらに大きくしています。例えば、米国では、血液製剤施設は食品医薬品局（FDA）の規制を受け、FDAの現行製造管理基準（cGMP）要件に準拠しなければなりません。コンプライアンス違反は、罰則や風評被害、さらには営業停止につながることもあります。このような規制上の課題やコンプライアンス要件は、開発・商品化の複雑さとコストを増大させるため、市場成長の抑制要因となっています。

製品カテゴリー別では、機器セグメントが市場を独占する

輸血診断市場は、製品別に試薬・キット、機器、その他に分類することができます。試薬・キットは、感染症の検出、血液型判定、適合性検査など、さまざまな検査やアッセイに使用され、輸血診断において重要な役割を担っています。これらの製品は消耗品であり、継続的な補充が必要であるため、高い需要があります。試薬・キット分野は、献血活動の増加や輸血感染症の流行増加などの要因から、2023年から2031年の予測期間中に最も高いCAGRで成長すると予想されます。自動分析装置やラボラトリー機器を含む機器は、診断テストを実施し、正確な結果を得るために不可欠です。これらの機器は、効率、精度、スループットを向上させ、輸血診断での高い採用率に寄与しています。したがって、高度な診断技術への需要と効率的なラボプロセスの必要性により、2022年には機器部門が収益面で大きなシェアを占めています。その他」セグメントには、制御材料、校正器、品質管理ソリューションなど、輸血診断で使用される補助製品および付属品が含まれます。このセグメントの市場シェアは相対的に小さいが、輸血診断のプロセス全体をサポートする上で重要な役割を果たしています。

血液型分類の用途別セグメントが市場を席巻

輸血診断市場は、用途によって血液型分類と疾患スクリーニングに分類されます。血液型分類は、輸血の際にドナーとレシピエントの適合性を確保するために、個人の血液型とRh因子を決定することを含みます。これは、輸血を安全かつ成功させるために不可欠なステップです。血液型検査は、世界中の血液銀行、病院、研究所で日常的に行われている検査であるため、2022年の市場では、血液型検査部門が大きな収益シェアを占めています。血液・血液製剤の需要の増加、輸血処置の件数の増加が、血液型分類セグメントの成長を後押ししています。疾患スクリーニングでは、輸血によって感染する可能性のあるさまざまな感染症や疾患の検出と診断が行われます。これには、HIV、肝炎、梅毒、マラリアなどの疾患スクリーニングが含まれます。疾患スクリーニングは、感染症の感染を防ぎ、ドナーとレシピエントの両方の健康を守るために重要です。血液の安全性が重視され、感染症検査に関する厳しい規制が実施されていることから、疾患スクリーニング分野は2023年から2031年の予測期間中に高いCAGRを示すと予想されます。

北米が収益をリードし、予測期間中はAPACが成長をリードする

北米は、確立された医療インフラ、血液の安全性に関する高い意識、厳格な規制基準により、2022年の市場において収益の大きなシェアを占めています。また、この地域は、高度な医療施設や充実した輸血サービスの恩恵を受けています。欧州は、輸血処置の増加、血液関連疾患の有病率の上昇、高度な診断技術の採用が進んでいることを背景に、市場シェアで北米に次ぐ地位を占めています。アジア太平洋地域は、中国やインドなどの国々における患者数の多さ、医療インフラの改善、医療費の増加などの要因により、2023年から2031年の予測期間中に最も高いCAGRを示すと予想されます。また、血液の安全性に関する意識の高まりや、輸血処置に関する厳格な規制の実施も、この地域の市場成長に寄与しています。ラテンアメリカと中東・アフリカ地域は、医療施設の改善、献血率の増加、血液の安全対策強化の取り組みによって、輸血診断市場で安定した成長を示しています。

市場競争は予測期間中に激化へ

輸血診断市場は競争が激しく、複数の主要企業が市場での存在感を高め、競争優位に立とうと努力しています。市場の有力企業には、Bio-Rad Laboratories Inc.、Grifols、Immucor Inc.、Ortho Clinical Diagnostics、Quotient Limited、Beckman Coulter Inc.、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、Becton、Dickinson and Company、Siemens Healthineersなどがあります。これらの企業は、市場での地位を維持し、成長を促進するために様々な戦略に注力しています。輸血診断市場で企業が採用する主な戦略の1つは、製品開発とイノベーションです。市場企業は、技術的に高度で信頼性の高い診断ソリューションを導入するために、研究開発活動に多額の投資を行っています。輸血診断の精度、スピード、効率を向上させ、検査能力の向上と血液製剤の安全性を確保することを目的としています。コラボレーション、パートナーシップ、買収は、この市場で企業が採用するその他の注目すべき戦略です。戦略的提携により、企業は互いの強みを生かし、地理的範囲を拡大し、製品ポートフォリオの幅を広げることを目的としています。血液銀行、病院、研究機関との提携は、企業が強力な顧客基盤を確立し、より広い市場へのアクセスを獲得するのに役立ちます。

市場概要
輸血診断市場：製品別 2021-2031
輸血診断市場：用途別 2021-2031
輸血診断市場：最終用途別 2021-2031
輸血診断市場：地域別 2021-2031
- 英国・欧州連合
  - 英国
  - ドイツ
  - スペイン
  - イタリア
  - フランス
  - その他欧州地域

第10章アジア太平洋の輸血診断市場 2021-2031

市場概要
輸血診断市場：製品別 2021-2031
輸血診断市場：用途別 2021-2031
輸血診断市場：最終用途別 2021-2031
輸血診断市場：地域別 2021-2031
- アジア太平洋
  - 中国
  - 日本
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域

第11章ラテンアメリカの輸血診断市場 2021-2031

市場概要
輸血診断市場：製品別 2021-2031
輸血診断市場：用途別 2021-2031
輸血診断市場：最終用途別 2021-2031
輸血診断市場：地域別 2021-2031
- ラテンアメリカ
  - ブラジル
  - メキシコ
  - その他ラテンアメリカ地域

第12章中東・アフリカの輸血診断市場 2021-2031

市場概要
輸血診断市場：製品別 2021-2031
輸血診断市場：用途別 2021-2031
輸血診断市場：最終用途別 2021-2031
輸血診断市場：地域別 2021-2031
- 中東・アフリカ
  - GCC
  - アフリカ
  - その他中東・アフリカ地域

第13章企業プロファイル

Bio-Rad Laboratories Inc.
Grifols
Immucor Inc.
Ortho Clinical Diagnostics
Quotient Limited
Beckman Coulter Inc.
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Becton
Dickinson and Company
Siemens Healthineers
その他の注目企業

図表

List of Tables

TABLE 1 Global Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 2 Global Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 3 Global Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 4 North America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 5 North America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 6 North America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 7 U.S. Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 8 U.S. Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 9 U.S. Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 10 Canada Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 11 Canada Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 12 Canada Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 13 Rest of North America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 14 Rest of North America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 15 Rest of North America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 16 UK and European Union Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 17 UK and European Union Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 18 UK and European Union Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 19 UK Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 20 UK Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 21 UK Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 22 Germany Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 23 Germany Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 24 Germany Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 25 Spain Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 26 Spain Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 27 Spain Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 28 Italy Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 29 Italy Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 30 Italy Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 31 France Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 32 France Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 33 France Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 34 Rest of Europe Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 35 Rest of Europe Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 36 Rest of Europe Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 37 Asia Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 38 Asia Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 39 Asia Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 40 China Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 41 China Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 42 China Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 43 Japan Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 44 Japan Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 45 Japan Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 46 India Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 47 India Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 48 India Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 49 Australia Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 50 Australia Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 51 Australia Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 52 South Korea Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 53 South Korea Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 54 South Korea Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 55 Latin America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 56 Latin America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 57 Latin America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 58 Brazil Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 59 Brazil Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 60 Brazil Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 61 Mexico Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 62 Mexico Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 63 Mexico Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 64 Rest of Latin America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 65 Rest of Latin America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 66 Rest of Latin America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 67 Middle East and Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 68 Middle East and Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 69 Middle East and Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 70 GCC Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 71 GCC Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 72 GCC Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 73 Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 74 Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 75 Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
TABLE 76 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
TABLE 77 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
TABLE 78 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)

List of Figures

FIG. 1 Global Blood Transfusion Diagnostics Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Blood Transfusion Diagnostics Market: Quality Assurance
FIG. 5 Global Blood Transfusion Diagnostics Market, By Product, 2022
FIG. 6 Global Blood Transfusion Diagnostics Market, By Application, 2022
FIG. 7 Global Blood Transfusion Diagnostics Market, By End-use, 2022
FIG. 8 Global Blood Transfusion Diagnostics Market, By Geography, 2022
FIG. 9 Market Geographical Opportunity Matrix - Global Blood Transfusion Diagnostics Market, 2022
FIG. 10 Market Positioning of Key Blood Transfusion Diagnostics Market Players, 2022
FIG. 11 Global Blood Transfusion Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
FIG. 12 Global Blood Transfusion Diagnostics Market, By Product, 2022 Vs 2031, %
FIG. 13 Global Blood Transfusion Diagnostics Market, By Application, 2022 Vs 2031, %
FIG. 14 Global Blood Transfusion Diagnostics Market, By End-use, 2022 Vs 2031, %
FIG. 15 U.S. Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 16 Canada Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 17 Rest of North America Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 18 UK Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 19 Germany Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 20 Spain Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 21 Italy Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 22 France Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 23 Rest of Europe Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 24 China Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 25 Japan Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 26 India Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 27 Australia Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 28 South Korea Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 29 Rest of Asia Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 30 Brazil Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 31 Mexico Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 32 Rest of Latin America Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 33 GCC Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 34 Africa Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
FIG. 35 Rest of Middle East and Africa Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031

Product Code: 139607-06-23

The blood transfusion diagnostics market is a critical segment of the healthcare industry that plays a crucial role in ensuring safe and efficient blood transfusion practices. The market is expected to grow at a CAGR of 7% during the forecast period of 2023 to 2031. This market is driven by the increasing demand for blood and blood products, rising awareness about transfusion-transmitted infections, and the need for accurate and efficient diagnostic methods. The market revenue has been steadily growing, and it is expected to continue its upward trajectory in the coming years. The market's revenue is influenced by factors such as the increasing number of blood transfusions due to surgical procedures, trauma cases, and chronic diseases. Additionally, the rising prevalence of blood-related disorders and the growing geriatric population contribute to the demand for blood transfusion diagnostics. The advancements in technology have led to the development of innovative diagnostic methods that provide accurate and rapid results, further fuelling market growth. In recent years, there has been a growing emphasis on the prevention and control of transfusion-transmitted infections. This has led to the introduction of stringent regulatory guidelines and quality assurance programs, which drive the adoption of advanced blood transfusion diagnostics. The market is witnessing a shift from conventional serological methods to nucleic acid testing (NAT) and other molecular techniques for improved sensitivity and specificity.

Growing Demand for Blood and Blood Products

The increasing demand for blood and blood products is a major driver of the blood transfusion diagnostics market. This demand stems from various factors such as surgical procedures, trauma cases, and the treatment of chronic diseases. According to the World Health Organization (WHO), an estimated 112.5 million units of blood donations are collected globally each year. The demand for blood transfusions is expected to rise further due to the growing prevalence of diseases such as cancer and cardiovascular disorders, which often require blood transfusions during treatment.

Rising Awareness about Transfusion-Transmitted Infections

The awareness and concern regarding transfusion-transmitted infections (TTIs) have been on the rise, driving the need for effective blood transfusion diagnostics. TTIs are infections that can be transmitted through the transfusion of contaminated blood or blood products. The implementation of stringent regulatory guidelines and quality assurance programs by healthcare authorities and blood banks has further emphasized the importance of accurate and reliable diagnostics. For example, the Centers for Disease Control and Prevention (CDC) in the United States has established guidelines for the screening and testing of blood donors to minimize the risk of TTIs. This increased awareness has led to the adoption of advanced diagnostic methods, including nucleic acid testing (NAT), to detect infectious agents with higher sensitivity and specificity.

Advancements in Diagnostic Technologies

Advancements in diagnostic technologies have significantly contributed to the growth of the blood transfusion diagnostics market. The development of innovative tests and systems that offer improved accuracy, rapid results, and enhanced automation has transformed the field of blood transfusion diagnostics. For instance, the introduction of NAT techniques, such as polymerase chain reaction (PCR) and real-time PCR, has revolutionized the detection of infectious agents in donated blood. These molecular-based methods offer high sensitivity and specificity, enabling the early detection of pathogens and reducing the risk of transfusion-transmitted infections. Furthermore, advancements in automation and robotics have streamlined laboratory processes, allowing for higher throughput and efficiency in blood transfusion diagnostics. These technological advancements continue to drive the market forward by providing healthcare professionals with reliable and efficient tools for ensuring safe blood transfusions.

Regulatory Challenges and Stringent Compliance Requirements

One of the key restraints in the blood transfusion diagnostics market is the presence of regulatory challenges and stringent compliance requirements. The blood transfusion process involves several regulatory standards and guidelines aimed at ensuring the safety and quality of blood products. These regulations are implemented to minimize the risk of transfusion-transmitted infections and other adverse events. However, compliance with these regulations can be complex and resource-intensive for healthcare facilities and blood banks. The process of obtaining regulatory approvals, conducting validation studies, and adhering to quality control measures can be time-consuming and costly. Additionally, the constant updates and revisions to regulatory standards add to the challenges faced by industry players. For example, in the United States, blood establishments are regulated by the Food and Drug Administration (FDA) and must comply with the FDA's Current Good Manufacturing Practices (cGMP) requirements. Non-compliance can result in penalties, reputational damage, and even the suspension of operations. These regulatory challenges and compliance requirements pose a restraint on market growth, as they increase the complexity and cost of developing and commercializing blood transfusion diagnostics.

Instruments Segment Dominates the Market by Product Categories

The blood transfusion diagnostics market can be segmented based on products into reagents & kits, instruments, and others. Reagents & kits play a crucial role in blood transfusion diagnostics as they are used for various tests and assays to detect infectious agents, blood group typing, and compatibility testing. These products have a high demand due to their consumable nature and the need for continuous replenishment. The reagents & kits segment is expected to grow at the highest CAGR during the forecast period of 2023 to 2031, attributed to factors such as increasing blood donation activities and the rising prevalence of transfusion-transmitted infections. Instruments, including automated analyzers and laboratory equipment, are essential for performing diagnostic tests and ensuring accurate results. These instruments offer improved efficiency, precision, and throughput, contributing to their high adoption in blood transfusion diagnostics. The instruments segment, therefore, held a substantial share in terms of revenue in 2022, driven by the demand for advanced diagnostic technologies and the need for efficient laboratory processes. The "others" segment includes ancillary products and accessories used in blood transfusion diagnostics, such as control materials, calibrators, and quality control solutions. Although this segment may have a relatively smaller market share, it plays a vital role in supporting the overall blood transfusion diagnostics process.

Blood Grouping Segment Dominated the Market by Application

The blood transfusion diagnostics market can be categorized based on applications into blood grouping and disease screening. Blood grouping involves determining an individual's blood type and Rh factor to ensure compatibility between the donor and recipient during transfusions. It is an essential step in ensuring safe and successful blood transfusions. The blood grouping segment held a significant revenue share in the market in 2022 as it is a routine procedure performed in blood banks, hospitals, and laboratories worldwide. The increasing demand for blood and blood products, along with the rising number of transfusion procedures, drives the growth of the blood grouping segment. Disease screening involves the detection and diagnosis of various infectious diseases and conditions that can be transmitted through blood transfusions. This includes screening for diseases such as HIV, hepatitis, syphilis, and malaria, among others. Disease screening is critical to prevent the transmission of infections and safeguard the health of both the donor and recipient. The disease screening segment is expected to exhibit a higher CAGR during the forecast period of 2023 to 2031, due to the growing emphasis on blood safety and the implementation of stringent regulations regarding infectious disease testing.

North America to Lead Revenues, While APAC to Lead the Growth During the Forecast Period

North America held a significant share of revenues in the market in 2022 due to well-established healthcare infrastructure, high awareness about blood safety, and stringent regulatory standards. The region also benefits from advanced healthcare facilities and extensive blood transfusion services. Europe follows North America in terms of market share, driven by increasing blood transfusion procedures, rising prevalence of blood-related disorders, and growing adoption of advanced diagnostic technologies. The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period of 2023 to 2031, due to factors such as a large patient population, improving healthcare infrastructure, and increasing healthcare expenditure in countries like China and India. Rising awareness about blood safety and the implementation of strict regulations for blood transfusion procedures also contribute to the market growth in this region. Latin America and the Middle East & Africa regions are witnessing steady growth in the blood transfusion diagnostics market, driven by improving healthcare facilities, increasing blood donation rates, and efforts to enhance blood safety measures.

Market Competition to Intensify During the Forecast Period

The blood transfusion diagnostics market is highly competitive, with several key players striving to enhance their market presence and gain a competitive edge. Prominent companies in the market include Bio-Rad Laboratories Inc., Grifols, Immucor Inc., Ortho Clinical Diagnostics, Quotient Limited, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, and Siemens Healthineers, among others. These players focus on various strategies to maintain their market position and drive growth. One of the key strategies adopted by companies in the blood transfusion diagnostics market is product development and innovation. Market players invest significantly in research and development activities to introduce technologically advanced and reliable diagnostic solutions. They aim to enhance the accuracy, speed, and efficiency of blood transfusion diagnostics, offering improved testing capabilities and ensuring the safety of blood products. Collaborations, partnerships, and acquisitions are other notable strategies employed by companies in this market. Through strategic alliances, companies aim to leverage each other's strengths, expand their geographic reach, and broaden their product portfolios. Collaborations with blood banks, hospitals, and research institutions help companies establish a strong customer base and gain access to a wider market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Blood Transfusion Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Blood Transfusion Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Reagents & Kits
Instruments
Others

Application

Blood Grouping
Disease Screening
Serological Disease Screening
Molecular Disease Screening

End-use

Hospitals
Blood Banks
Diagnostic Laboratories
Others

Region Segment (2021-2031; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Blood Transfusion Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Blood Transfusion Diagnostics market?

Which is the largest regional market for Blood Transfusion Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Blood Transfusion Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Blood Transfusion Diagnostics market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Blood Transfusion Diagnostics Market
2.2. Global Blood Transfusion Diagnostics Market, By Product, 2022 (US$ Million)
2.3. Global Blood Transfusion Diagnostics Market, By Application, 2022 (US$ Million)
2.4. Global Blood Transfusion Diagnostics Market, By End-use, 2022 (US$ Million)
2.5. Global Blood Transfusion Diagnostics Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022

3. Blood Transfusion Diagnostics Market: Competitive Analysis

3.1. Market Positioning of Key Blood Transfusion Diagnostics Market Vendors
3.2. Strategies Adopted by Blood Transfusion Diagnostics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Blood Transfusion Diagnostics Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Blood Transfusion Diagnostics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Reagents & Kits
- 5.3.2. Instruments
- 5.3.3. Others

6. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Blood Grouping
- 6.3.2. Disease Screening
- 6.3.3. Serological Disease Screening
- 6.3.4. Molecular Disease Screening

7. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Hospitals
- 7.3.2. Blood Banks
- 7.3.3. Diagnostic Laboratories
- 7.3.4. Others

8. North America Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
8.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
8.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
8.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 8.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

9. UK and European Union Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
9.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
9.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
9.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.4.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.4.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.5.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.5.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 9.5.1.6.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.6.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

10. Asia Pacific Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
10.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
10.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
10.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.4.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.4.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.5.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.5.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 10.5.1.6.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.6.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

11. Latin America Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
11.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
11.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
11.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 11.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

12. Middle East and Africa Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
12.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
12.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
12.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
    - 12.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

13. Company Profile

13.1. Bio-Rad Laboratories Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. Grifols
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. Immucor Inc.
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. Ortho Clinical Diagnostics
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. Quotient Limited
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. Beckman Coulter Inc.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. F. Hoffmann-La Roche Ltd.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. Abbott Laboratories
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. Becton
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. Dickinson and Company
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Siemens Healthineers
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
13.12. Other Notable Players
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives

輸血診断市場 - 成長、将来展望、競合分析、2023年～2031年

Blood Transfusion Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

血液・血液製剤の需要拡大

輸血感染症に対する意識の高まり

診断技術の進歩

規制上の課題と厳格なコンプライアンス要件

製品カテゴリー別では、機器セグメントが市場を独占する

血液型分類の用途別セグメントが市場を席巻

北米が収益をリードし、予測期間中はAPACが成長をリードする

市場競争は予測期間中に激化へ

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 輸血診断市場：競合分析

第4章 輸血診断市場：マクロ分析と市場力学

第5章 輸血診断市場：製品別 2021-2031

第6章 輸血診断市場：用途別 2021-2031

第7章 輸血診断市場：最終用途別 2021-2031

第8章 北米の輸血診断市場 2021-2031

第9章 英国・欧州連合の輸血診断市場 2021-2031

第10章 アジア太平洋の輸血診断市場 2021-2031

第11章 ラテンアメリカの輸血診断市場 2021-2031

第12章 中東・アフリカの輸血診断市場 2021-2031

第13章 企業プロファイル